Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Put Yourself In The CEO’s Shoes: Audience Makes Drug Pricing And Investment Decisions At EHFG

Executive Summary

A pricing simulation exercise at the recent EHFG conference gave delegates an idea of the multiple factors that have to be taken into account when setting the price of a new drug for a rare disease – and deciding which candidate molecules are worth investing in.

You may also be interested in...



Scrip Company Of The Year Celgene In Rude Health Despite Hiccups

Celgene, which continues to plough back a very high proportion of its revenues into R&D, remains the preferred partner of choice for biotechs who hope to bring the next wave of innovative products to the market, Kevin Loth, VP of corporate affairs and policy in Europe tells Scrip.

What EU Governments Need To Do About Access To Affordable Medicines

In a wide-ranging discussion at the recent European Health Forum Gastein, policy makers explored big-picture challenges and ideas of what governments should do to ensure access to increasingly expensive medicines as pressures grow on national health care systems.

Pandemic Treaty: WHO To Broadcast Videos Of Stakeholders ‘Wishlists’

Hundreds of videos have been sent in by people interested in contributing to the future pandemic treaty proposed by the World Health Organization.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS122044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel